Mallory Morales, Cpa Email & Phone Number

Cambridge, Ma, Us

Senior Finance Executive, Interim-Chief Financial Officer reporting to CEOPrincipal Financial Officer and Principal Accounting OfficerImmuneering Corporation (Nasdaq: IMRX) is a clinical-stage oncology company developing medicines for broad populations of cancer patients with an initial aim to develop a universal-RAS therapy. The company aims to achieve universal activity through deep cyclic inhibition of the MAPK pathway, impacting cancer cells while sparing healthy cells. Immuneering’s lead product candidate, IMM-1-104, is in a Phase 1/2a study in patients with advanced solid tumors harboring RAS mutations. The company’s development pipeline also includes IMM-6-415, which is designed to have an accelerated cadence relative to IMM-1-104, as well as several early-stage programs.

Cambridge, Ma, Us

Interim-Chief Financial OfficerPrincipal Financial Officer and Principal Accounting Officer

Foster City, Ca, Us

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. As senior finance leader, I am currently focused on the smooth integration of Immunomedics R&D organization into Gilead Sciences.

Morris Plains, New Jersey, Us

Immunomedics Inc (IMMU) - Acquired by Gilead Sciences October 2020Immunomedics, a leading Antibody Drug Conjugate company with 450+ employees, focused on bringing Trodelvy® to the US market commercially and expanding clinical treatment globally for Triple Negative Breast Cancer (TNBC), Urothelial Cancer (UC) and other cancers under clinical study. I am proud to be a member of this great team of IMMU colleagues whose hard work and dedication led to our first FDA approval in metastatic triple-negative breast cancer. As a Sr. finance leader and strategic business partner, my focus is on developing annual operating budget, forecasting and planning (FP&A) for Clinical R&D Operations, developing dashboards and scenarios providing valuable insight to guide the decision making process.

Paris, Fr

Key Accomplishments and Responsibilities:•Director of finance and controller for four Global Brands and one very unique brand that was launched internally by a small niche team of experts within L'Oreal•Oversaw and managed all brand financial and accounting functions including management and executive reporting; oversight of accounting; interface with auditors and preparation of budgets and forecasts•Developed Global Sales dashboard for each brand GM on a monthly and quarterly reporting including commentary to help guide and influence the Global brands commercial and marketing strategy•Lead team on construction of budgets/forecasts/trends as well as analysis vs actuals for full P&L •Gross Margin Management and review of new product launches to ensure products meeting category COGS % benchmarks•Review return on investment related to digital spend, advertising and promotional activities, advise on highest return investment opportunities based on results•Review from a finance perspective SOWs, agency and model contracts and coordinate with corporate legal team •Determine appropriate cost allocation methodology for shared costs globally among the markets•Compile and distribute quarterly transfer pricing file for new launches to be used for budget and trend prep by zones and countries •Attend development meetings on key projects and analyze spending vs budgets •Standardized monthly reporting process of business results to General Managers and Senior Management in Paris•Provided ad hoc requests and analyses to Paris management, GMs and Marketing heads for strategic senior management meetings. •Co-developed and built 5 Year P&L and business plan in support new brand launched in 2018•Co-developed Profit acceleration 5-year plan for Brand that was dilutive to the overall division•Performed Sku rationalization exercise to reduce the number of under-performing and dilutive skus to Gross Margin•Developed KPIs and monitoring for digital/social media investments

Paris, Fr

Within just a couple months of joining the Company, I automated numerous areas of reporting, validation and analysis which were manually keyed in by my predecessor. I did this by utilizing excel formulas and lookups to pull the data from various sources. The efficiencies gained allowed for more time to proactively analyze and question performance results to each division. As a result, catching more errors and/or obtain commentary to share with Corporate HQ in Paris before being questioned. Further, with the time saved it has also allowed me to get involved with special projects and presentations as noted below.• Responsible for monthly reporting and consolidation of 4 divisions inclusive of all brands• Responsible for overseeing Professional Products and Luxury Products divisions’ budgeting, trend, three-year plan and actual reporting of profit and loss results• Serve as primary contact with corporate finance in Paris, France• Assessing, interpreting and applying the L’Oreal Group Normes• Perform a variety of supervisory tasks including; employee training, instructing CPE classes, development and performance management activities• Responsible for and selected member of the internal controls committee in USA • Prepare and review quarterly senior management presentation on business overview and performance• Prepare various analysis of new acquisitions including assess performance of business against discounted cash flows and original business plan and board plan compared to actual current Trend.• Ensure expenses are classified in accordance with L’Oreal Group Normes. • Coordinate with Brand Finance teams, Operations and Supply Chain• Review new product launch plans and analysis • Perform multiple adhoc projects, analysis and requests by the North America CFO• Key member in the implementation and validation of new ERP system and development of standardized reporting for all divisions for senior management meetings

Gb

Key Accomplishments and Responsibilities:Audit Clients: Within the Pharmaceutical and Biotech Industries•Responsible for managing and leading audit team of 4 associates (staff and senior) •Plan and prepare audit plan and strategy, ensure PwC Methodologies and Best Practices are applied.•Examine financial and accounting records, legal documents and other tangible items such as plant and equipment or observe processes or procedures being performed. •Responsible for consultations on technical accounting matters with client and specialists within PwC•Recognized and respected by client to be a trusted advisor •Evaluated as "Higher than Expected" in annual performance review for FY 2011 through FY 2013•Communicated performance expectations according to the specific demands of the engagement and what is expected of staff at the start of fieldwork.•Testing and review of internal controls•Demonstrated proficient knowledge and understanding of U.S. GAAP, U.S. GAAS, IFRS and FASB ASC Codification •Developed firm personnel by instructing training sessions and provide real time feedback and coaching to staff •Review and audit 10Qs/10Ks/8Ks and proper filing with SEC•Business combinations, carve-out audits, acquisition accounting, pensions, investment valuations

Gb

Key Accomplishments and Responsibilities:Audit Clients: Managed Futures, Registered Hedge Funds and Private Equity Funds •Responsible for the audits of over 200 hedge funds and private equity fund of funds •Presented Sarbanes Oxley 404 Implementation project to 30 members of the ML accounting team•Lead reviewer for 51 ML GPC Private Equity Funds•Perform significant and detailed analytical procedures using graphs and presentations•Managed 6 staff associates and 1 senior associate and provided instruction and feedback for all•Managed audit engagement workload and client communications •Updated Accounting and Reporting Manual ("ARM") for Investment Companies with National PwC Office.•ASC 820 Fair Value Measurements and disclosures, FASB ASC 946, Financial Services - Investment Companies •Exposure to various products (Futures, Fx Forwards, Options, swaps, long-short securities, privately held)•Performed valuation of level 3 investments and due diligence surrounding valuation reported by management.

Gb

Audit Clients: Primary clients in the Retail Industry and Manufacturing Industry•Work within a team to assist and supervise audit engagements applying academic skills and experience in accounting and auditing. Gained experience in half-year reviews, year end and internal control audits.•Manage staff of 2-3 individuals on each engagement•Evaluated the efficiency and effectiveness of the client’s internal control structure and provide recommendations for business improvements.•Researched accounting standards and pronouncements for the completion of annual financial statements and related disclosures to ensure that financial statements are prepared in accordance with GAAP•Demonstrated the ability to multi-task and prioritize within a demanding environment while instructing and trained staff on the Firm’s audit approach and client specific issues, coordinate information requests from the client, while meeting manager’s expectations.•Developed appropriate audit approach during year end audits and reviews in response to changing market and industry risk factors.•Perform analytical procedures at planning stage, during fieldwork and final stage of financial statement review

Bs, Accounting

Bachelor Of Science - Bs, Accounting And Business